Download interactions: TXT MITAB-2.5
| Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
|---|---|---|---|---|---|---|
|
ACTB
Actin, cytoplasmic 1 |
4 |
19 |
High-throughput |
0.903 | High |
|
|
ACTC
Actin, alpha cardiac muscle 1 |
3 |
16 |
High-throughput |
0.775 | High |
|
|
POTEI
POTE ankyrin domain family member I |
2 |
17 |
High-throughput |
0.726 | High |
|
|
ACTA
Actin, aortic smooth muscle |
2 |
18 |
High-throughput |
0.726 | High |
|
|
ACTBL
Beta-actin-like protein 2 |
2 |
18 |
High-throughput |
0.726 | High |
|
|
ACTG
Actin, cytoplasmic 2 |
1 |
18 |
High-throughput |
0.691 | High |
|
|
1433F
14-3-3 protein eta |
3 |
20 |
High-throughput |
0.662 | High |
|
|
TMOD3
Tropomodulin-3 |
2 |
2 |
High-throughput |
0.628 | High |
|
|
1433G
14-3-3 protein gamma |
3 |
20 |
High-throughput |
0.604 | High |
|
|
BCL7A
B-cell CLL/lymphoma 7 protein family member A |
2 |
3 |
High-throughput |
0.574 | High |
|
|
BCL7C
B-cell CLL/lymphoma 7 protein family member C |
2 |
3 |
High-throughput |
0.574 | High |
|
|
1433T
14-3-3 protein theta |
1 |
20 |
High-throughput |
0.489 | High |
|
|
RASK
GTPase KRas |
1 |
14 |
High-throughput |
0.479 | High |
|
|
CADH1
Cadherin-1 |
1 |
6 |
High-throughput |
0.479 | High |
|
|
SRC
Proto-oncogene tyrosine-protein kinase Src |
1 |
14 |
High-throughput |
0.479 | High |
|
|
NCK1
SH2/SH3 adapter protein NCK1 |
1 |
18 |
High-throughput |
0.479 | High |
|
|
P85A
Phosphatidylinositol 3-kinase regulatory subunit alpha |
1 |
3 |
High-throughput |
0.479 | High |
|
|
CRK
Adapter molecule crk |
1 |
19 |
High-throughput |
0.479 | High |
|
|
RHOB
Rho-related GTP-binding protein RhoB |
1 |
20 |
High-throughput |
0.479 | High |
|
|
GRB2
Growth factor receptor-bound protein 2 |
1 |
20 |
High-throughput |
0.479 | High |
|
|
H2B1H
Histone H2B type 1-H |
1 |
19 |
High-throughput |
0.470 | High |
|
|
PLCG1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 |
1 |
0 |
High-throughput |
0.458 | High |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024
